Sitarest DM Tablets – Sitagliptin 100mg Depa 10mg Met 500mg Tablets Manufacturer, Supplier, Franchise In India

Sitarest DM Tablets are a triple-combination oral antidiabetic medicine formulated for comprehensive management of type 2 diabetes mellitus. This advanced formulation combines Sitagliptin 100 mg, Dapagliflozin 10 mg, and Metformin 500 mg, targeting multiple pathophysiological defects of diabetes. Sitarest DM is especially beneficial for patients who require intensive glycemic control when dual therapy is insufficient.

Type 2 diabetes is a complex metabolic disorder involving insulin resistance, impaired insulin secretion, and increased glucose production. Sitarest DM addresses all these mechanisms in a single tablet. Metformin reduces hepatic glucose output and improves insulin sensitivity, Sitagliptin enhances incretin hormone activity to regulate insulin and glucagon secretion, and Dapagliflozin promotes urinary glucose excretion. This multi-targeted approach ensures effective and sustained blood sugar control throughout the day.

Key Benefits of Sitagliptin 100mg Depa 10mg Met 500mg Tablets

Triple-action blood glucose control
Effective reduction of HbA1c levels
Low risk of hypoglycemia when used appropriately
Helps in weight management
Improves insulin sensitivity and efficiency
Provides added heart and kidney protection
Convenient fixed-dose combination improves patient compliance